Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

European head and neck society issues recommendations for head and neck cancer survivorship care

European head and neck society issues recommendations for head and neck cancer survivorship care

WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers

WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers

Olaparib for high-risk, early-stage breast cancer approved in Europe

Olaparib for high-risk, early-stage breast cancer approved in Europe

WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab + chemotherapy in mNSCLC

WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab +...

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...

Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths

Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer

FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer

FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC: DOLPHIN Study

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC:...

WCLC 2022: IASLC Early Detection and Screening Committee report on global obstacles to lung cancer screening in low-to middle-income countries

WCLC 2022: IASLC Early Detection and Screening Committee report on global obstacles to lung cancer screening in...

More from ecancer